Navigation Links Reports 38% Year-Over-Year Revenue Growth in the First Quarter 2012

CINCINNATI, Sept. 5, 2012 /PRNewswire/ --, Inc. (OTC: HEWA) a leading VIPPS accredited retail mail-order pharmacy, today announced its financial results for the first quarter ended March 31, 2012.

In the first quarter of 2012, the Company's quarterly net sales increased to $3,153,607 from $2,284,552, up 38% compared to the same period in 2011. 

Selling, general and administrative expenses (SG&A) increased by $730,780 in the first quarter of 2012 compared to the same period in 2011.  Net loss in the first quarter of 2012 increased to $1,550,312, as compared with a net loss of $1,071,279 for the same period in 2011. The increase in SG&A expenses and net loss was due primarily to the expansion of resources to handle growth of the Company's prescription sales.

"We are pleased with the growth we continue to see with our business," said Lalit Dhadphale, President and CEO of "We remain focused on execution and are excited by the solid sales we've witnessed from the recent generic launches of Plavix® and Lipitor®. We expect this momentum to continue with the recent releases of generic Actos® and Singulair®. Additionally, we intend to take increasing market share over the next few quarters by expanding our sales channels and exceeding customer expectations."

About, Inc., Inc. (OTC: HEWA) is a trusted VIPPS-accredited retail mail-order pharmacy based in the Cincinnati area. offers more than 300 prescription drugs for $3.50 with 100% FREE shipping and is a three-time consecutive winner of the BizRate Circle of Excellence Award for outstanding customer satisfaction and service. With a mission to provide affordable healthcare to every American by eliminating inefficiencies in the drug distribution chain, has become the leading online pharmacy in the United States. is licensed in all 50 states and DC, and only sells drugs which are FDA-approved and legal for sale in the United States.  Visit online at

Actos® is a registered trademark of Takeda Pharmaceutical Company Limited.

Lipitor® is a registered trademark of Pfizer Corporation.

Plavix® is a registered trademark of Sanofi-Aventis.

Singulair® is a registered trademark of Merck & Co., Inc.

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. and Northwest Physicians Network Partner to Provide Exclusive Discount Pharmacy Services to Patients
2. Reports 82% Year-Over-Year Revenue Growth
3. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
4. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
5. MGC Diagnostics Corporation Reports Third Quarter Fiscal Year 2012 Operating Results
6. Groupe Athena Inc., (OTC: GATA) Reports Audited Financials, Announces Record Revenue & Profits
7. China Nepstar Chain Drugstore Reports Second Quarter 2012 Financial Results
8. China Kanghui Holdings Reports Second Quarter 2012 Financial Results
9. Concord Medical Reports Second Quarter 2012 Financial Results
10. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
11. Organovo Reports Q2 2012 Financial Results, Provides Business Update
Post Your Comments:
(Date:12/1/2015)... --  MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), a ... an Investigational New Drug Application (IND) with the U.S. ... fully human antibody product HuMab 5B1 as a therapeutic ... the Phase I clinical trial early in 2016. ... planned Phase I trial will evaluate the safety, tolerability ...
(Date:12/1/2015)... 2015  Booth #3506 – Claymount is featuring its full ... of the Radiological Society of North America ... Based in the Netherlands , Claymount is ... (NYSE: VAR ) and is one of the world,s ... state automatic exposure control systems for controlling dose during medical ...
(Date:12/1/2015)... , Dec. 1, 2015  Lexicon Pharmaceuticals, ... that top-line data from its TELECAST Phase ... in treating carcinoid syndrome in cancer patients ... clinical benefit observed in its pivotal TELESTAR ... a companion to TELESTAR primarily to provide ...
Breaking Medicine Technology:
(Date:12/1/2015)... Viejo, CA (PRWEB) , ... December 01, 2015 , ... ... length of footage, and with full control over customization, the possibilities are truly endless, ... frame rate, position randomization, overlay depth position, vertical flip, horizontal flip, depth of field ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... receiving the 2015 HSJ Acute Sector Innovation Award on November 18th. This prestigious ... care experience, and propose exciting enhancements to the medical landscape. , The UCLH ...
(Date:11/30/2015)... Cary, NC (PRWEB) , ... November 30, 2015 ... ... Dominique Dawes, Amanda Beard and Brooke Bennett are collaborating with brands across various ... , These four influential figures make up an elite group of Gold Medal ...
(Date:11/30/2015)... , ... December 01, 2015 , ... ... Christina Colon as a 2015-2016 inductee into its VIP Woman of the ... NAPW is the nation’s leading networking organization exclusively for professional women, boasting 850,000 ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... programs of the19th Bi-National Convention of the Federation of Philippine American Chambers of ... in Las Vegas, Nevada. , 1Heart Caregiver Services, as an active delegate ...
Breaking Medicine News(10 mins):